Skip to main content

Together we are beating cancer

Donate now

PSA test

Showing 9 out of 9 results
Sample bottles in a lab

A spit test that predicts people's genetic risk of prostate cancer could help find more cases earlier, according to the BARCODE 1 trial. A spit test that predicts people's genetic risk of prostate cancer could help find more cases earlier, according to the BARCODE 1 trial.

by Tim Gunn | News | 1 June 2024

1 June 2024

A man talking to a GP

Why isn’t there a screening programme for prostate cancer? Here, we take a look at some of the latest research into PSA testing to find out.  Why isn’t there a screening programme for prostate cancer? Here, we take a look at some of the latest research into PSA testing to find out. 

by Amy Warnock | Analysis | 6 April 2024

6 April 2024

Photograph of a person having an MRI scan.

New research has found that using an advanced MRI technique may enable doctors to pinpoint potentially aggressive or fast-growing cancers and guide treatment pathways. New research has found that using an advanced MRI technique may enable doctors to pinpoint potentially aggressive or fast-growing cancers and guide treatment pathways.

by Lilly Matson | Analysis | 14 February 2022

14 February 2022

prostate cancer biopsy
  • Health & Medicine
  • Science & Technology

Targeted prostate cancer screening: Are we there yet?

Prostate cancer screening is back in the news, as results from a targeted screening programme are released. But when it comes to yearly checks, are we there yet? Prostate cancer screening is back in the news, as results from a targeted screening programme are released. But when it comes to yearly checks, are we there yet?

by Katie Roberts | Analysis | 20 October 2021

20 October 2021

Cancer Research UK logo

A genetic pattern could predict how aggressive prostate cancer is before treatment, and whether the disease will come back in men who have already been treated, according to research published in the Lancet Oncology*. A genetic pattern could predict how aggressive prostate cancer is before treatment, and whether the disease will come back in men who have already been treated, according to research published in the Lancet Oncology*.

by Cancer Research UK | News | 9 February 2011

9 February 2011

Cancer Research UK logo

CANCER RESEARCH UK scientists have shown that screening for prostate cancer using prostate specific antigen (PSA) would lead to a substantial number of tumours diagnosed at an earlier and more treatable stage. However, there would be likely cases of overdiagnosed prostate cancer according to a study published in the British Journal of Cancer today. CANCER RESEARCH UK scientists have shown that screening for prostate cancer using prostate specific antigen (PSA) would lead to a substantial number of tumours diagnosed at an earlier and more treatable stage. However, there would be likely cases of overdiagnosed prostate cancer according to a study published in the British Journal of Cancer today.

by Cancer Research UK | News | 1 April 2009

1 April 2009

Cancer Research UK logo

Male relatives of prostate cancer patients need more information in order to help them understand the possible familial risk of the disease, and to decide whether or not to have a PSA test, according to research published in the British Journal of Cancer today (21 February 2006). Male relatives of prostate cancer patients need more information in order to help them understand the possible familial risk of the disease, and to decide whether or not to have a PSA test, according to research published in the British Journal of Cancer today (21 February 2006).

by Cancer Research UK | News | 21 February 2006

21 February 2006